Earnings History Data for Capricor Therapeutics, Inc. (CAPR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29-02-2024 | AH | CAPR | Capricor Therapeutics, Inc. | 121.94 | -0.02 | -0.23 | -0.31 | Capricor Therapeutics GAAP EPS of -$0.02 beats by $0.18, revenue of $12.08M beats by $1.48M [2/29/2024 4:16 PM] |
4.57 | 0.37 (8.81%) |
4.49 | 0.29 (6.90%) |
2.68 - 8.22 | 353,575 | 190,000 | 7,692 | ||
| 14-11-2023 | AH | CAPR | Capricor Therapeutics, Inc. | 72.18 | -0.25 | -0.27 | -0.26 | Capricor Therapeutics GAAP EPS of -$0.25 beats by $0.05, revenue of $6.19M beats by $3.02M [11/14/2023 4:08 PM] |
3.19 | 0.19 (6.15%) |
3.01 | 0.0 (0.00%) |
2.68 - 8.22 | 225,280 | 200,000 | 7,595 | ||
| 07-08-2023 | AH | CAPR | Capricor Therapeutics, Inc. | 112.20 | -0.29 | -0.34 | -0.29 | Capricor Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $3.92M beats by $2.32M [8/7/2023 4:32 PM] |
5.71 | 1.00 (21.23%) |
5.00 | 0.29 (6.16%) |
3.30 - 6.58 | 315,313 | 40,000 | 901 | ||
| 11-05-2023 | AH | 4:00 PM ET (May 11) |
CAPR | Capricor Therapeutics, Inc. | 101.84 | -0.31 | -0.32 | -0.32 | Capricor Therapeutics GAAP EPS of -$0.31 beats by $0.01, revenue of $2.98M beats by $2.48M [5/11/2023 4:03 PM] |
4.06 | -0.05 (-1.22%) |
4.20 | 0.09 (2.24%) |
2.81 - 6.58 | 61,431 | 50,000 | 642 | |
| 15-03-2023 | AH | 4:00 PM ET (Mar 15) |
CAPR | Capricor Therapeutics, Inc. | 108.54 | -0.31 | 0.00 | -0.26 | Capricor Therapeutics GAAP EPS of -$0.31 beats by $0.03, revenue of $0.96M beats by $0.96M [3/15/2023 4:03 PM] |
4.52 | 0.05 (1.12%) |
4.64 | 0.17 (3.80%) |
2.81 - 6.58 | 135,016 | 90,000 | 1,122 | |
| 10-11-2022 | AH | 4:05 PM ET (Nov 10) |
CAPR | Capricor Therapeutics, Inc. | 119.05 | -0.26 | -0.28 | -0.17 | Capricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45M [11/10/2022 4:03 PM] |
4.55 | -0.35 (-7.14%) |
4.90 | 0.0 (0.00%) |
2.56 - 6.58 | 200,402 | 140,000 | 175 | |
| 10-08-2022 | AH | 4:00 PM ET (Aug 10) |
CAPR | Capricor Therapeutics, Inc. | 108.00 | -0.29 | -0.25 | -0.21 | Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03 [8/10/2022 4:14 PM] |
5.30 | 0.78 (17.26%) |
4.70 | 0.18 (3.98%) |
2.56 - 5.85 | 546,716 | 100,000 | 12,816 | |
| 10-05-2022 | AH | 4:00 PM ET (May 10) |
CAPR | Capricor Therapeutics, Inc. | 84.89 | -0.32 | 0.00 | -0.23 | Capricor Therapeutics GAAP EPS of -$0.32 [5/10/2022 4:06 PM] |
2.91 | -0.32 (-9.95%) |
3.18 | 0.06 (1.92%) |
2.56 - 6.22 | 107,902 | 90,000 | 120 | |
| 10-03-2022 | AH | 4:05 PM ET (Mar 10) |
CAPR | Capricor Therapeutics, Inc. | 106.98 | -0.26 | -0.19 | -0.21 | 4.22 | 0.10 (2.43%) |
4.24 | 0.12 (2.91%) |
2.56 - 6.22 | 166,951 | 180,000 | 4,058 | ||
| 09-11-2021 | AH | 4:00 PM ET (Nov 9) |
CAPR | Capricor Therapeutics, Inc. | 87.71 | -0.17 | -0.22 | -0.20 | Capricor Therapeutics EPS beats by $0.06 [11/9/2021 4:09 PM] |
3.50 | -0.12 (-3.31%) |
3.62 | 0.0 (0.00%) |
3.13 - 8.40 | 257,395 | 160,000 | 4,734 | |
| 12-08-2021 | AH | 4:05 PM ET (Aug 12) |
CAPR | Capricor Therapeutics, Inc. | 102.04 | -0.21 | -0.23 | -0.23 | Capricor Therapeutics EPS beats by $0.02, misses on revenue [8/12/2021 4:13 PM] |
4.03 | -0.44 (-9.93%) |
4.08 | -0.40 (-8.93%) |
3.13 - 8.40 | 411,531 | 110,000 | 32,880 | |
| 13-05-2021 | AH | 4:00 PM ET (May 13) |
CAPR | Capricor Therapeutics, Inc. | 80.48 | -0.23 | 0.00 | -0.30 | Capricor Therapeutics reports Q1 results [5/13/2021 4:21 PM] |
3.64 | 0.48 (15.19%) |
3.35 | 0.19 (6.01%) |
3.13 - 12.32 | 620,944 | 520,000 | 2,699 | |
|
||||||||||||||||||
| 11-03-2021 | AH | 4:00 PM ET (Mar 11) |
CAPR | Capricor Therapeutics, Inc. | 105.30 | -0.21 | 0.00 | -0.34 | Capricor Therapeutics EPS misses by $0.01 [3/11/2021 4:04 PM] |
5.18 | -0.36 (-6.59%) |
4.88 | -0.66 (-11.91%) |
0.88 - 12.32 | 504,669 | 423,807 | 22,425 | |
| 12-11-2020 | AH | 4:00 PM ET (Nov 12) |
CAPR | Capricor Therapeutics, Inc. | 83.43 | -0.20 | 0.00 | -0.43 | Capricor Therapeutics reports Q3 results [11/12/2020 4:07 PM] |
4.34 | -0.30 (-6.56%) |
4.22 | -0.43 (-9.25%) |
0.88 - 12.32 | 400,311 | 711,590 | 6,045 | |
|
|
||||||||||||||||||
| 06-08-2020 | AH | 4:00 PM ET (Aug 6) |
CAPR | Capricor Therapeutics, Inc. | 109.55 | -0.23 | -0.37 | -0.59 | Capricor Therapeutics EPS beats by $0.11 [8/6/2020 4:05 PM] |
6.48 | -1.42 (-17.97%) |
6.49 | -1.41 (-17.85%) |
0.88 - 12.32 | 3,732,419 | 8,324,786 | 215,305 | |
|
|
||||||||||||||||||